Conditions: HCC – Hepatocellular Carcinoma
Interventions: Drug: eparlitozoviril; Other: Control group
Sponsors: Tianjin Medical University Cancer Institute and Hospital
Active, not recruiting Conditions: HCC – Hepatocellular Carcinoma
Interventions: Drug: eparlitozoviril; Other: Control group
Sponsors: Tianjin Medical University Cancer Institute and Hospital
Active, not recruiting
